Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research

Internal Medicine Journal

Volumn 37, Issue 1, 2007, Pages 12-17

  Newcombe, J P ^a   Kerridge, I H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical trial; Conflict of interest; Pharmaceutical sponsorship; Research ethics; Research ethics committee

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS; FINANCIAL MANAGEMENT; HUMAN; PATIENT CARE; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

CLINICAL TRIALS; CONFLICT OF INTEREST; DATA COLLECTION; DISCLOSURE; DRUG INDUSTRY; ETHICS COMMITTEES, RESEARCH; GUIDELINES; HUMAN EXPERIMENTATION; NEW SOUTH WALES; RESEARCH PERSONNEL; RESEARCH SUPPORT;

EID: 33845520620     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01234.x     Document Type: Article

References (20)

1. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373-80.
2. Commonwealth of Australia. Pharmaceuticals Industry Action Agenda: Local Priority - Global Partner. Canberra: Commonwealth of Australia; 2002.
3. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289: 454-65.
4. Boyd EA, Bero LA. Assessing faculty financial relationships with industry: a case study. JAMA 2000; 284: 2209-14.
5. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167-70.
6. Ethical Guidelines in the Relationship between Physicians and the Pharmaceutical Industry [homepage on the Internet]. Sydney: The Royal Australasian College of Physicians [cited 2005 Sep 14]. Available from URL: http://www.racp.edu.au/public/Ethical_guide_pharm.pdf
7. Joint NHMRC/AVCC Statement and Guidelines on Research Practice [homepage on the Internet]. Canberra: National Health and Medical Research Council; 1997 [updated 2005 Jun 29; cited 2005 Sep 14]. Available from URL: http://www.nhmrc.gov.au/funding/policy/researchprac.htm
8. Commonwealth of Australia. National Statement on Ethical Conduct in Research Involving Humans. Canberra: Commonwealth of Australia; 1999.
9. Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest at US universities. JAMA 2000; 284: 2203-8.
10. Lo B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. N Engl J Med 2000; 343: 1616-20.
11. McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 2000; 343: 1621-6.
12. Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O'Bannon JM III, Goldrich MS et al. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002; 287: 78-84.
13. Blumenthal D. Doctors and drug companies. N Engl J Med 2004; 351: 1885-90.
14. Chalmers D, Pettit P. Towards a consensual culture in the ethical review of research. Med J Aust 1998; 168: 79-82.
15. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry - self-regulation in the shadow of federal prosecution. N Engl J Med 2004; 351: 1891-900.
16. Levinsky NG. Nonfinancial conflicts of interest in research. N Engl J Med 2002; 347: 759-61.
17. National Ethics Application Form (NEAF). [homepage on the Internet]. Canberra: National Health and Medical Research Council [updated 2006 4 Jul; cited 10 September 2006]. Available from http://nhmrc.gov.au/ethics/human/ahec/ neaf.htm
18. Sarson-Lawrence M, Alt C, Mok MT, Dodds M, Rosenthal, MA. Trust and confidence: towards mutual acceptance of ethics committee approval of multicentre studies. Intern Med J 2004; 34: 598-603.
19. Walsh MK, McNeil JJ, Breen KJ. Improving the governance of health research. Med J Aust 2005; 182: 468-71.
20. Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep 2004; 34: 18-23.